Pillstats
Rx only · Solution · Respiratory (Inhalation)

Ipratropium Bromide

Ipratropium Bromide

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)203212
US makers12 labelers
Packages30
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.032$0.064$0.096$0.127Dec 2025Apr 2026Jul 2026
$0.111
Latest avg · Jul 22, 2026
+6%
Since Dec 17, 2025
12
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

34K68K102K136K2025 Q12025 Q22025 Q32025 Q42026 Q1
101K
Rx · 2026 Q1
11.6M
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Nephron Pharmaceuticals Corporationunknown5SUPPLYING
Aurobindo Pharma Limitedunknown4SUPPLYING
Mylan Pharmaceuticals Inc.unknown4SUPPLYING
Ritedose Pharmaceuticals, LLCunknown4SUPPLYING
Rising Pharma Holdings, Inc.unknown3SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown3SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
Redpharm Drugunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose …

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.